Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant

Robert G Adamo1, Eric Lam2, Jean-Paul Salameh1

  • 1Faculty of Medicine at The University of Ottawa, Ottawa, ON, Canada.

Insights

The Liver Imaging Reporting and Data System (LI-RADS) major features are consistently associated with hepatocellular carcinoma (HCC) risk across various patient factors. This suggests LI-RADS can be applied universally to at-risk populations without modification.

Area of Science:

  • Radiology and Medical Imaging
  • Hepatology
  • Oncology

Background:

  • Guidelines suggest Liver Imaging Reporting and Data System (LI-RADS) applicability may vary in certain hepatocellular carcinoma (HCC) risk populations.
  • Limited data exist on the association between HCC risk factors and LI-RADS major features.
  • This study addresses the gap by evaluating these associations.

Purpose of the Study:

  • To determine if the association between HCC risk factors and CT/MRI LI-RADS major features differs among individuals at risk for HCC.
  • To provide evidence for the universal application of LI-RADS in at-risk populations.

Main Methods:

  • A systematic search of multiple databases (MEDLINE, Embase, Cochrane, Scopus) from 2014-2022.
  • Individual participant data (IPD) meta-regression analysis of 23 studies (2958 patients).
  • Assessment of interactions between LI-RADS major features and HCC risk factors (age, sex, cirrhosis, HBV).

Main Results:

  • The association between LI-RADS major features and HCC was consistent across various HCC risk factors.
  • P-values ranged from 0.09 to 0.99, indicating no significant differences.
  • Sensitivity analysis of low-bias studies confirmed primary findings.

Conclusions:

  • CT/MRI LI-RADS major features' association with HCC risk factors does not significantly differ in at-risk individuals.
  • CT/MR LI-RADS should be applied to all patients deemed at risk by the system, without modification.
  • Findings support the standardized use of LI-RADS for HCC risk assessment.